The Lancet Oncology in conversation with

207 Episodes

1. Wanda Cui on measuring ovarian toxicity

   Published: 10/3/2023
2. Ticiana Leal on Tumour Treating Fields

   Published: 9/1/2023
3. Xuesong Han on cancer diagnosis during the COVID-19 pandemic in the USA

   Published: 8/2/2023
4. Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma

   Published: 7/3/2023
5. Madeline Pe on the SISAQOL initiative

   Published: 5/31/2023
6. Kadia Petricca and Joyce Kambugu on access to essential cancer medicines for children

   Published: 5/2/2023
7. Mark Lythgoe on UK oncology drug approval after Brexit

   Published: 3/27/2023
8. Janet Brown on the phase 2/3 STAR trial

   Published: 2/28/2023
9. Valerie Speirs on biomarkers in male breast cancer

   Published: 1/30/2023
10. Sameer Bakhshi on sex disparities in childhood cancer in India

    Published: 1/3/2023
11. Shankar Siva on radiotherapy for primary renal cell carcinoma

    Published: 11/28/2022
12. Mark Lawler and Richard Sullivan on the European Groundshot

    Published: 11/15/2022
13. Samar Alhomoud on challenges for cancer control in the Gulf region

    Published: 10/31/2022
14. Inge Marie Svane on mRNA vaccines for cancer treatment

    Published: 9/27/2022
15. Eline Giraud and Elise Smolders on QT interval prolongation potential of anticancer

    Published: 8/30/2022
16. Ignace Vergote and Maria Kyrgiou on gynaecological cancers

    Published: 7/25/2022
17. David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer

    Published: 6/30/2022
18. Wilfred Ngwa, Beatrice Wiafe-Addai, and David Kerr on cancer in sub-Saharan Africa

    Published: 5/9/2022
19. Georgios Lyratzopoulos on emergency presentation

    Published: 4/28/2022
20. Lisa Iezzoni on disabilities and cancer, and Jordan Marchak on mental health problems in young cancer survivors

    Published: 3/29/2022